Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study suggests potential bidirectional causal links between certain sleep traits, like insomnia and reduced sleep duration, and types of alopecia, including alopecia areata; however, these associations did not hold after correcting for multiple tests, warranting cautious interpretation.

This study found that low serum ferritin levels were significantly associated with non-scarring alopecia in women from Punjab, Pakistan, suggesting that assessing ferritin could help identify iron deficiency as a modifiable factor in hair loss.

Hair loss negatively impacts quality of life, and psychological support can help.

In this retrospective study, researchers reported that low-dose oral minoxidil significantly improved hair density in 60 patients with androgenetic alopecia or telogen effluvium over 4-8 months, as detected through standardized AI-powered imaging.

Low-dose oral minoxidil is safe for the heart in the short term for hair loss patients.

This review reports that while current treatments for non-scarring alopecia, like minoxidil and finasteride, have limited efficacy due to side effects, natural remedies may offer more effective management with potentially fewer side effects, though their varying safety profiles call for further investigation.

In this review, the researchers reported that current treatments for non-scarring alopecia, including minoxidil, finasteride, and JAK inhibitors, have limited efficacy and adverse effects, whereas natural remedies might offer more effective management with fewer side effects, though further research on their safety is needed.

In this study, researchers examined vitamin D levels and blood count parameters in children and adolescents with non-scarring alopecia, finding significant vitamin D deficiency but no significant differences in deficiency or insufficiency across different types of alopecia.

This case report highlights that tumid lupus erythematosus should be considered in the differential diagnosis of annular scalp lesions with non-scarring alopecia, emphasizing histopathological examination for accurate diagnosis.

This prospective observational study investigated 200 patients with non-scarring alopecia, concluding that accurate classification combined with individualized treatment, including combination therapies, significantly improved outcomes over monotherapy with topical minoxidil.

In this study conducted at a tertiary care center, androgenetic alopecia was found to be the most prevalent type of non-scarring alopecia, especially among males, while telogen effluvium was more common in females, with the highest incidence in individuals aged 21-30.

The researchers reported that asynchronous teledermatology effectively diagnosed and managed non-scarring alopecia in 91.3% of cases within the UPMC network, improving access for underserved populations, with high engagement from Black and Asian patients and significant participation from those living outside Pittsburgh.

In this study, researchers found that although vitamin D deficiency was common among patients with non-scarring alopecia, the prevalence of vitamin D insufficiency was also comparable in the control group, suggesting a need for community-level vitamin D fortification.

In this review, the authors concluded that trichoscopy is a quick, non-invasive, and effective method for diagnosing and monitoring non-scarring alopecia, offering a more precise and faster alternative compared to other diagnostic methods for identifying and managing different types of hair loss.

This study highlights the limited knowledge about using iron infusions to treat alopecia in patients intolerant to oral iron, suggesting a need for further research.

This review addresses the causes, mechanisms, and treatment options for the most common non-scarring alopecias in females, including telogen effluvium, alopecia areata, and female pattern hair loss.

This study using Mendelian randomization found that higher levels of circulating β-carotene and α-tocopherol may reduce the risk of androgenetic alopecia, while α-tocopherol may also protect against alopecia areata, suggesting diet-derived antioxidants could aid in preventing non-scarring alopecia.

In this case report, a 38-year-old woman with Degos disease and non-scarring alopecia experienced significant hair regrowth with the current treatment protocol, highlighting its potential effectiveness in such complex conditions.

In this study, a bidirectional Mendelian randomization analysis found a causal link between alopecia areata and hypothyroidism, indicating that each condition may influence the other, while no similar relationship was observed between androgenetic alopecia and hypothyroidism.

This study aimed to document and compare the prevalence and characteristics of hair loss in patients with systemic lupus erythematosus, noting the differences in trichoscopic and histopathologic evaluations between those with and without alopecia. Results are not reported.

This study found that patients with non-scarring alopecia, such as androgenetic alopecia and female pattern hair loss, have lower serum levels of 25-hydroxyvitamin D and a higher incidence of vitamin D deficiency compared to healthy controls.

This research investigated immune cell involvement in various types of inflammatory alopecia by analyzing gene expression data from scalp samples, revealing distinct cellular changes in conditions like Alopecia Areata, Frontal Fibrosing Alopecia, Lichen Planopilaris, and Central Centrifugal Cicatricial Alopecia, which may inform future therapeutic targets.

In this study conducted at the Vitebsk Regional Clinical Center, digital video microscopy without biopsy effectively identified diagnostic criteria for non-scarring alopecia in 315 patients, allowing for the prescription of appropriate treatments for alopecia areata and androgenetic alopecia.

In this study, using a shampoo with Morus alba root extract over 12 weeks increased hair density and shaft thickness in patients with mild to moderate non-scarring alopecia, with both investigators and participants noting visible improvements and moderate satisfaction.

This study provides an updated overview of non-scarring alopecia in lupus erythematosus patients, revealing that diffuse/patchy NSA and lupus hair are strongly associated with systemic activity and respond well to SLE therapy, while progression to scarring alopecia was rare.

This study found that videodermoscopy is a promising non-invasive tool for distinguishing between types of non-scarring alopecia on the scalp, highlighting its potential in dermatological practice.

This study found that Muslim women who wear the hijab experienced an earlier onset of non-scarring alopecia compared to those who do not, with vitamin D deficiency and seborrheic dermatitis potentially contributing to the development of telogen effluvium in this group.

This study found that SLE patients with hair loss exhibited significant differences in the size and number of sebaceous glands compared to those without hair loss, but showed no histopathological differences between affected and unaffected scalp areas.

This study found that lower serum ferritin levels are associated with an increased risk of non-scarring alopecia in non-menopausal women, indicating that assessing iron stores is important for managing this condition.

In this study, females experienced a more significant decrease in quality of life from alopecia than males, with androgenetic alopecia causing greater impairment than alopecia areata.